The first human trial of COVID-19 vaccine Nanocovax began in Vietnam on December 17 with the first three volunteers. After 72 hours, they are in good health condition.
The first human trial of COVID-19 vaccine Nanocovax began in Vietnam on December 17 with the first three volunteers. After 72 hours, they are in good health condition.
 |
| (Source: VNA) |
